Arrow Financial Corp Amgen Inc Transaction History

Arrow Financial Corp

  • $1.07 Billion
  • Q3 2024

A detailed history of Arrow Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Arrow Financial Corp holds 14,688 shares of AMGN stock, worth $4.33 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
14,688
Previous 13,065 12.42%
Holding current value
$4.33 Million
Previous $4.08 Million 15.92%
% of portfolio
0.44%
Previous 0.4%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$309.38 - $337.38 $502,123 - $547,567
1,623 Added 12.42%
14,688 $4.73 Million
Q2 2024

Jul 30, 2024
BUY
$262.75 - $319.31 $925,931 - $1.13 Million
3,524 Added 36.94%
13,065 $4.08 Million
Q1 2024

May 21, 2024
SELL
$268.87 - $324.56 $277,742 - $335,270
-1,033 Reduced 9.77%
9,541 $2.71 Million
Q4 2023

Feb 12, 2024
SELL
$255.7 - $288.46 $71,596 - $80,768
-280 Reduced 2.58%
10,574 $3.05 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $990,484 - $1.23 Million
-4,530 Reduced 29.45%
10,854 $2.92 Million
Q2 2023

Aug 09, 2023
SELL
$214.27 - $253.37 $7,499 - $8,867
-35 Reduced 0.23%
15,384 $3.42 Million
Q1 2023

May 03, 2023
SELL
$225.79 - $275.2 $30,481 - $37,152
-135 Reduced 0.87%
15,419 $3.73 Million
Q4 2022

Feb 01, 2023
SELL
$229.03 - $291.01 $390,496 - $496,172
-1,705 Reduced 9.88%
15,554 $4.09 Million
Q2 2022

Jul 25, 2022
SELL
$230.71 - $256.74 $85,362 - $94,993
-370 Reduced 2.1%
17,259 $4.2 Million
Q1 2022

Apr 26, 2022
SELL
$219.27 - $242.57 $38,372 - $42,449
-175 Reduced 0.98%
17,629 $4.26 Million
Q4 2021

Jan 28, 2022
SELL
$198.88 - $227.6 $359,773 - $411,728
-1,809 Reduced 9.22%
17,804 $4.01 Million
Q3 2021

Oct 21, 2021
SELL
$212.27 - $248.7 $179,155 - $209,902
-844 Reduced 4.13%
19,613 $4.17 Million
Q2 2021

Jul 21, 2021
SELL
$233.58 - $259.14 $65,402 - $72,559
-280 Reduced 1.35%
20,457 $4.99 Million
Q1 2021

Apr 30, 2021
SELL
$221.91 - $258.6 $15,977 - $18,619
-72 Reduced 0.35%
20,737 $5.16 Million
Q4 2020

Feb 08, 2021
SELL
$216.38 - $257.67 $264,199 - $314,615
-1,221 Reduced 5.54%
20,809 $4.78 Million
Q3 2020

Nov 06, 2020
SELL
$234.65 - $260.95 $64,528 - $71,761
-275 Reduced 1.23%
22,030 $5.6 Million
Q2 2020

Jul 27, 2020
SELL
$197.81 - $242.74 $27,693 - $33,983
-140 Reduced 0.62%
22,305 $5.26 Million
Q1 2020

Apr 21, 2020
SELL
$182.24 - $241.7 $67,064 - $88,945
-368 Reduced 1.61%
22,445 $4.55 Million
Q4 2019

Feb 10, 2020
SELL
$189.21 - $243.2 $172,181 - $221,312
-910 Reduced 3.84%
22,813 $5.5 Million
Q3 2019

Oct 28, 2019
SELL
$174.11 - $208.62 $484,025 - $579,963
-2,780 Reduced 10.49%
23,723 $4.59 Million
Q2 2019

Jul 26, 2019
SELL
$166.7 - $195.41 $67,846 - $79,531
-407 Reduced 1.51%
26,503 $4.88 Million
Q1 2019

Apr 26, 2019
BUY
$180.87 - $203.88 $31,652 - $35,679
175 Added 0.65%
26,910 $5.11 Million
Q4 2018

Feb 04, 2019
BUY
$178.4 - $208.25 $268,492 - $313,416
1,505 Added 5.97%
26,735 $5.2 Million
Q3 2018

Oct 11, 2018
BUY
$185.29 - $208.89 $10,005 - $11,280
54 Added 0.21%
25,230 $5.23 Million
Q2 2018

Jul 30, 2018
SELL
$166.05 - $186.51 $49,150 - $55,206
-296 Reduced 1.16%
25,176 $4.65 Million
Q1 2018

Apr 25, 2018
SELL
$169.43 - $198.0 $33,716 - $39,402
-199 Reduced 0.78%
25,472 $4.34 Million
Q4 2017

Feb 05, 2018
SELL
$168.79 - $188.59 $41,353 - $46,204
-245 Reduced 0.95%
25,671 $4.47 Million
Q3 2017

Oct 18, 2017
BUY
$167.29 - $191.0 $4.34 Million - $4.95 Million
25,916
25,916 $4.83 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Arrow Financial Corp Portfolio

Follow Arrow Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email